Navigation Links
Japanese Cancer Patients Will Have Access to Compensator-Based IMRT with Opening of .decimal, Inc. Office in Tokyo and Hiring of Key Personnel
Date:11/4/2009

SANFORD, Fla., April 13 /PRNewswire/ -- .decimal, Inc., leading manufacturer of patient-specific medical devices, opens their first international office in Tokyo, Japan. An office in Japan will further strengthen .decimal's commitment to the Japanese market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO )

Richard Sweat, President/CEO of .decimal said, "The opening of an office in Japan is another example of our dedication to provide cancer patients around the world with innovative treatment solutions."

Japan is the second largest market in the world for medical devices and has a $20 billion medical device industry, with $5 billion in U.S. imports, according to the International Trade Administration. With an increasing number of patients with chronic diseases in Japan, medical devices to treat age-related diseases shows the potential for steady growth.

"After visiting Japan, meeting with medical universities and doctors and reviewing our market research, it was evident which market would be the next opportunity for us to grow globally. It is our understanding that there are over 700 radiation therapy centers and more than 1,000 full-time medical doctors in Japan - a substantial statistic," said Mark Mills, Senior Vice President of Sales and Marketing for .decimal. "We are excited to bring our products to market in Japan and we believe an authorized office is the appropriate next step."

.decimal will be providing cancer institutions in Japan the devices necessary to deliver compensator-based Intensity Modulated Radiation Therapy, an advanced form for delivering radiation. Compensators provide the maximum dose to the tumor, while providing maximum protection to the surrounding healthy tissues and organs, reducing the risk of acute and chronic damage. .decimal is in the process of being cleared by Japanese regulatory agencies and looks forward to begin offering their products commercially overseas.

"Cancer centers in Japan will soon have the opportunity to enhance their current radiation delivery capabilities through our unique pay-as-you-go, Internet-based manufacturing business model," said Sweat.

.decimal will be represented in Japan by Sam Tabuchi of Enterprise Florida-Japan. The .decimal office will be located at:

    Sagamiya #2 Building 5F
    10 Ichibancho
    Chiyoda-ku, Tokyo 102-0082
    Phone: 03-3230-0505

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced IMRT delivery, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years and serves more than 200 customers. For more information concerning .decimal, please see its Web site at www.dotdecimal.com.

SOURCE .decimal, Inc.


'/>"/>
SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
3. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
4. Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
5. The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ushijima for his Oncology Research
6. BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... 24, 2016 Research and ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" report ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, ... Structural electronics involves electronic and/or electrical components ... replacing dumb structures such as vehicle bodies or ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):